Fact sheet: Carnegie Medical

Fund information

Fund name
Carnegie Medical 1A EUR
Fund company manager
Carnegie Asset Management
Fund type
SIB
Fund manager(s)
Angelica Fatouros
since 01/07/2008
Fund objective
The investment objective of the C WorldWide Medical fund is to achieve long-term capital growth by investing globally in a limited number of companies within the healthcare sector. Most of the investments are in the major pharmaceutical companies, but also in smaller and medium-sized companies.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

4.57 %

1 Year rank in sector

27/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 484.9 m

FE Risk score

163

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    77.6%
  • Continental Europe
    19.7%
  • UK
    2.7%
  • Pharmaceuticals
    41.4%
  • Biotechnology/Medical
    40.9%
  • Services
    17.7%
  • North American Equities
    77.6%
  • European Equities
    19.7%
  • UK Equities
    2.7%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund0.65 %-1.03 %4.57 %15.31 %73.87 %
Sector1.18 %8.1 %14.79 %27.68 %100.39 %
Rank within sector20 / 3128 / 3127 / 3023 / 2819 / 24
Quartile th3 rd4 th4 th4 th4 th

Calendar performance

YTD-20172016201520142013
Fund4.81 %-14.37 %10.68 %38.82 %31.94 %
Sector17.13 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector26 / 3020 / 3010 / 285 / 2517 / 24
Quartile th4 th3 rd2 nd1 st3 rd

Risk statistics

Alpha-4.22
Beta1.12
Sharpe-0
Volatility18.49
Tracking error7.08
Information ratio-0.54
R-Squared0.86

Price movement

52 week high101.85
52 week low82.43
Current bid price0
Current offer price0
Current mid price94.74

Holdings by region

  • 77.6% North America
  • 19.7% Continental Europe
  • 2.7% UK

Holdings by sector

  • 41.4% Pharmaceuticals
  • 40.9% Biotechnology/Medical
  • 17.7% Services

Holdings by asset type

  • 77.6% North American Equities
  • 19.7% European Equities
  • 2.7% UK Equities

Individual holdings

  • 6.7% JOHNSON & JOHNSON
  • 6.5% UNITEDHEALTH GROUP INC
  • 5.3% GILEAD SCIENCES INC
  • 4.8% C WORLDWIDE MEDICAL SMALL & MID CAP
  • 4.2% CELGENE CORP
  • 3.7% ROCHE HLDG AG
  • 3.6% AMGEN INC
  • 3.4% ACTAVIS INC
  • 3.2% PFIZER INC
  • 2.9% THERMO FISHER SCIENTIFIC INC